BACKGROUND: The 2013-2016 West African Ebola virus disease (EVD) epidemic is the largest recorded. Triage on the basis of clinical signs had limited success, and the time to diagnosis by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) could exceed 5 days. Here we describe the development and field validation of the ReEBOV Antigen Rapid Test (ReEBOV RDT) to aid triage of individuals with suspected EVD. METHODS: Samples from patients with suspected EVD were submitted to Kenema Government Hospital, Sierra Leone, for Lassa fever and EVD screening throughout 2014. Banked residual clinical samples were tested in November 2014 and January 2015 in a blinded field trial to estimate the clinical effectiveness of the ReEBOV RDT, compared with EBOV-specific qRT-PCR. RESULTS: Preliminary ReEBOV RDT performance demonstrated a positive percentage agreement (PPA) of 91.1% (195 of 214 results; 95% confidence interval [CI], 86.5%-94.6%) and a negative percentage agreement (NPA) of 90.2% (175 of 194; 95% CI, 85.1%-94.0%). The final estimates used by the Food and Drug Administration to determine whether to grant emergency use authorization for the test, which excluded a qRT-PCR reference method threshold cutoff, were a PPA of 62.1% (72 of 116 results; 95% CI, 52.6%-70.9%) and a NPA of 96.7% (58 of 60; 95% CI, 88.5%-99.6%), with a diagnostic likelihood of 18.6. A subsequent, independent evaluation by the World Health Organization generated results consistent with the preliminary performance estimates. CONCLUSIONS: The ReEBOV RDT demonstrated the potential to provide clinically effective rapid and accurate point-of-care test results and, thus, to be a powerful tool for increasing triage efficiency.
BACKGROUND: The 2013-2016 West African Ebola virus disease (EVD) epidemic is the largest recorded. Triage on the basis of clinical signs had limited success, and the time to diagnosis by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) could exceed 5 days. Here we describe the development and field validation of the ReEBOV Antigen Rapid Test (ReEBOV RDT) to aid triage of individuals with suspected EVD. METHODS: Samples from patients with suspected EVD were submitted to Kenema Government Hospital, Sierra Leone, for Lassa fever and EVD screening throughout 2014. Banked residual clinical samples were tested in November 2014 and January 2015 in a blinded field trial to estimate the clinical effectiveness of the ReEBOV RDT, compared with EBOV-specific qRT-PCR. RESULTS: Preliminary ReEBOV RDT performance demonstrated a positive percentage agreement (PPA) of 91.1% (195 of 214 results; 95% confidence interval [CI], 86.5%-94.6%) and a negative percentage agreement (NPA) of 90.2% (175 of 194; 95% CI, 85.1%-94.0%). The final estimates used by the Food and Drug Administration to determine whether to grant emergency use authorization for the test, which excluded a qRT-PCR reference method threshold cutoff, were a PPA of 62.1% (72 of 116 results; 95% CI, 52.6%-70.9%) and a NPA of 96.7% (58 of 60; 95% CI, 88.5%-99.6%), with a diagnostic likelihood of 18.6. A subsequent, independent evaluation by the World Health Organization generated results consistent with the preliminary performance estimates. CONCLUSIONS: The ReEBOV RDT demonstrated the potential to provide clinically effective rapid and accurate point-of-care test results and, thus, to be a powerful tool for increasing triage efficiency.
Authors: Adrienne R Trombley; Leslie Wachter; Jeffrey Garrison; Valerie A Buckley-Beason; Jordan Jahrling; Lisa E Hensley; Randal J Schoepp; David A Norwood; Augustine Goba; Joseph N Fair; David A Kulesh Journal: Am J Trop Med Hyg Date: 2010-05 Impact factor: 2.345
Authors: Florian Vogt; Gabriel Fitzpatrick; Gabriela Patten; Rafael van den Bergh; Kathryn Stinson; Luigi Pandolfi; James Squire; Tom Decroo; Hilde Declerck; Michel Van Herp Journal: Euro Surveill Date: 2015
Authors: Mara Jana Broadhurst; John Daniel Kelly; Ann Miller; Amanda Semper; Daniel Bailey; Elisabetta Groppelli; Andrew Simpson; Tim Brooks; Susan Hula; Wilfred Nyoni; Alhaji B Sankoh; Santigi Kanu; Alhaji Jalloh; Quy Ton; Nicholas Sarchet; Peter George; Mark D Perkins; Betsy Wonderly; Megan Murray; Nira R Pollock Journal: Lancet Date: 2015-06-25 Impact factor: 79.321
Authors: John S Schieffelin; Jeffrey G Shaffer; Augustine Goba; Michael Gbakie; Stephen K Gire; Andres Colubri; Rachel S G Sealfon; Lansana Kanneh; Alex Moigboi; Mambu Momoh; Mohammed Fullah; Lina M Moses; Bethany L Brown; Kristian G Andersen; Sarah Winnicki; Stephen F Schaffner; Daniel J Park; Nathan L Yozwiak; Pan-Pan Jiang; David Kargbo; Simbirie Jalloh; Mbalu Fonnie; Vandi Sinnah; Issa French; Alice Kovoma; Fatima K Kamara; Veronica Tucker; Edwin Konuwa; Josephine Sellu; Ibrahim Mustapha; Momoh Foday; Mohamed Yillah; Franklyn Kanneh; Sidiki Saffa; James L B Massally; Matt L Boisen; Luis M Branco; Mohamed A Vandi; Donald S Grant; Christian Happi; Sahr M Gevao; Thomas E Fletcher; Robert A Fowler; Daniel G Bausch; Pardis C Sabeti; S Humarr Khan; Robert F Garry Journal: N Engl J Med Date: 2014-10-29 Impact factor: 91.245
Authors: M Allison Arwady; Luke Bawo; Jennifer C Hunter; Moses Massaquoi; Almea Matanock; Bernice Dahn; Patrick Ayscue; Tolbert Nyenswah; Joseph D Forrester; Lisa E Hensley; Benjamin Monroe; Randal J Schoepp; Tai-Ho Chen; Kurt E Schaecher; Thomas George; Edward Rouse; Ilana J Schafer; Satish K Pillai; Kevin M De Cock Journal: Emerg Infect Dis Date: 2015-04 Impact factor: 6.883
Authors: Adrian Q N Mylne; David M Pigott; Joshua Longbottom; Freya Shearer; Kirsten A Duda; Jane P Messina; Daniel J Weiss; Catherine L Moyes; Nick Golding; Simon I Hay Journal: Trans R Soc Trop Med Hyg Date: 2015-06-17 Impact factor: 2.184
Authors: Jeffrey G Shaffer; Donald S Grant; John S Schieffelin; Matt L Boisen; Augustine Goba; Jessica N Hartnett; Danielle C Levy; Rachael E Yenni; Lina M Moses; Mohammed Fullah; Mambo Momoh; Mbalu Fonnie; Richard Fonnie; Lansana Kanneh; Veronica J Koroma; Kandeh Kargbo; Darin Ottomassathien; Ivana J Muncy; Abigail B Jones; Megan M Illick; Peter C Kulakosky; Allyson M Haislip; Christopher M Bishop; Deborah H Elliot; Bethany L Brown; Hu Zhu; Kathryn M Hastie; Kristian G Andersen; Stephen K Gire; Shervin Tabrizi; Ridhi Tariyal; Mathew Stremlau; Alex Matschiner; Darryl B Sampey; Jennifer S Spence; Robert W Cross; Joan B Geisbert; Onikepe A Folarin; Christian T Happi; Kelly R Pitts; F Jon Geske; Thomas W Geisbert; Erica Ollmann Saphire; James E Robinson; Russell B Wilson; Pardis C Sabeti; Lee A Henderson; S Humarr Khan; Daniel G Bausch; Luis M Branco; Robert F Garry Journal: PLoS Negl Trop Dis Date: 2014-03-20
Authors: Samuel J Crowe; Matthew J Maenner; Solomon Kuah; Bobbie Rae Erickson; Megan Coffee; Barbara Knust; John Klena; Joyce Foday; Darren Hertz; Veerle Hermans; Jay Achar; Grazia M Caleo; Michel Van Herp; César G Albariño; Brian Amman; Alison Jane Basile; Scott Bearden; Jessica A Belser; Eric Bergeron; Dianna Blau; Aaron C Brault; Shelley Campbell; Mike Flint; Aridth Gibbons; Christin Goodman; Laura McMullan; Christopher Paddock; Brandy Russell; Johanna S Salzer; Angela Sanchez; Tara Sealy; David Wang; Gbessay Saffa; Alhajie Turay; Stuart T Nichol; Jonathan S Towner Journal: Emerg Infect Dis Date: 2016-02 Impact factor: 6.883
Authors: Basilua Andre Muzembo; Kei Kitahara; Ayumu Ohno; Ngangu Patrick Ntontolo; Nlandu Roger Ngatu; Keinosuke Okamoto; Shin-Ichi Miyoshi Journal: Bull World Health Organ Date: 2022-06-01 Impact factor: 13.831
Authors: Saori Sakabe; Brian M Sullivan; Jessica N Hartnett; Refugio Robles-Sikisaka; Karthik Gangavarapu; Beatrice Cubitt; Brian C Ware; Dylan Kotliar; Luis M Branco; Augustine Goba; Mambu Momoh; John Demby Sandi; Lansana Kanneh; Donald S Grant; Robert F Garry; Kristian G Andersen; Juan Carlos de la Torre; Pardis C Sabeti; John S Schieffelin; Michael B A Oldstone Journal: Proc Natl Acad Sci U S A Date: 2018-07-23 Impact factor: 11.205
Authors: M L Boisen; J N Hartnett; A Goba; M A Vandi; D S Grant; J S Schieffelin; R F Garry; L M Branco Journal: Annu Rev Virol Date: 2016-08-15 Impact factor: 10.431
Authors: Cassio M Fontes; Barbara D Lipes; Jason Liu; Krystle N Agans; Aiwei Yan; Patricia Shi; Daniela F Cruz; Garrett Kelly; Kelli M Luginbuhl; Daniel Y Joh; Stephanie L Foster; Jacob Heggestad; Angus Hucknall; Maiken H Mikkelsen; Carl F Pieper; Roarke W Horstmeyer; Thomas W Geisbert; Michael D Gunn; Ashutosh Chilkoti Journal: Sci Transl Med Date: 2021-04-07 Impact factor: 17.956
Authors: Matthew L Boisen; Jessica N Hartnett; Jeffrey G Shaffer; Augustine Goba; Mambu Momoh; John Demby Sandi; Mohamed Fullah; Diana K S Nelson; Duane J Bush; Megan M Rowland; Megan L Heinrich; Anatoliy P Koval; Robert W Cross; Kayla G Barnes; Anna E Lachenauer; Aaron E Lin; Mahan Nekoui; Dylan Kotliar; Sarah M Winnicki; Katherine J Siddle; Michael Gbakie; Mbalu Fonnie; Veronica J Koroma; Lansana Kanneh; Peter C Kulakosky; Kathryn M Hastie; Russell B Wilson; Kristian G Andersen; Onikepe O Folarin; Christian T Happi; Pardis C Sabeti; Thomas W Geisbert; Erica Ollmann Saphire; S Humarr Khan; Donald S Grant; John S Schieffelin; Luis M Branco; Robert F Garry Journal: Sci Rep Date: 2018-04-12 Impact factor: 4.379
Authors: Manfred Weidmann; Ousmane Faye; Oumar Faye; Ahmed Abd El Wahed; Pranav Patel; Christophe Batejat; Jean Claude Manugerra; Aimee Adjami; Matthias Niedrig; Frank T Hufert; Amadou A Sall Journal: J Infect Dis Date: 2018-10-05 Impact factor: 5.226
Authors: Chantal B Reusken; Ramona Mögling; Pieter W Smit; Roland Grunow; Giuseppe Ippolito; Antonino Di Caro; Marion Koopmans Journal: Euro Surveill Date: 2018-05